Anhui Wanbang Pharmaceutical Technology Co Ltd Class A Shares 301520
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥39.27
- Day Range
- ¥39.40–41.90
- 52-Week Range
- ¥33.88–90.00
- Bid/Ask
- ¥40.80 / ¥40.82
- Market Cap
- ¥2.72 Bil
- Volume/Avg
- 3.7 Mil / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 20.97
- Price/Sales
- 6.72
- Dividend Yield (Trailing)
- 1.27%
- Dividend Yield (Forward)
- 1.27%
- Total Yield
- 1.27%
Company Profile
Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 479
- Website
- http://www.ahwbyy.cn
Comparables
Valuation
|
Metric
|
301520
|
300759
|
688399
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.97 | 26.82 | — |
Price/Book Value | 1.76 | 3.06 | 1.36 |
Price/Sales | 6.72 | 3.44 | 11.86 |
Price/Cash Flow | 21.80 | 15.29 | 672.94 |
Price/Earnings
301520
300759
688399
Financial Strength
|
Metric
|
301520
|
300759
|
688399
|
|---|---|---|---|
Quick Ratio | 19.29 | 1.41 | 5.79 |
Current Ratio | 20.34 | 1.81 | 6.10 |
Interest Coverage | — | 10.01 | −45.10 |
Quick Ratio
301520
300759
688399
Profitability
|
Metric
|
301520
|
300759
|
688399
|
|---|---|---|---|
Return on Assets (Normalized) | 9.63% | 5.12% | −8.31% |
Return on Equity (Normalized) | 10.33% | 9.91% | −9.66% |
Return on Invested Capital (Normalized) | 9.79% | 6.74% | −10.10% |
Return on Assets
301520
300759
688399
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Cqhytpxny | Rrcxq | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Mqxzxnngt | Lydkmh | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Zfkhclcl | Ncsvp | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Hrsglvyvf | Tvjl | $19.0 Bil | |||
| Viatris Inc
VTRS
| Gmcyzvhs | Yfvt | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vvzrzptr | Zzpf | $13.4 Bil | |||
| Catalent Inc
CTLT
| Bgcxbrjc | Xypbrvb | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Cxvnxhfhb | Yxghbl | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Cjxtcnnw | Vrf | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gjcmplwqwv | Vqvm | $2.5 Bil |
United States